{content}

Study list

Zuiani

United Kingdom United States of America
|
2023-2026
  • Adults
  • General population
  • Monkeypox virus
  • Monkeypox virus infection
  • Pharmacological intervention
  • Vaccination
  • BNT166a

LONGCOVID EXPERIENCE

Spain
|
2023-2024
  • Adults
  • General population
  • Elderly
  • Hospital wide
  • SARS-CoV-2
  • Post-COVID-19

Rösner

Germany
|
2023-2025
  • Adults
  • Elderly
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention

ALL-VASCOR

Poland
|
2023
  • Adults
  • Elderly
  • SARS-CoV-2
  • Post-COVID-19
  • Pharmacological intervention
  • Allopurinol

CoviVa

Germany
|
2023-2027
  • Adults
  • General population
  • Elderly
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Neurostimulation

MonVIP

France
|
2023
  • Adults
  • Fragile population
  • Immunocompromised host
  • People at high risk of STIs
  • People living with HIV
  • PrEP users
  • Hospital wide
  • Outpatient clinic
  • Infectious diseases unit
  • Monkeypox virus
  • Monkeypox virus infection

Stengel

Germany
|
2023
  • Adults
  • General population
  • Healthcare workers
  • Hospital wide
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation

Goedecke

Germany
|
2023-2025
  • Adults
  • Elderly
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Immunoadsorption

Bahr

Germany
|
2023
  • Adults
  • General population
  • Elderly
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19

PCS TeR

Germany
|
2023
  • General population
  • Elderly
  • Adult
  • Community
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation